Teresa Grieco


Titolo Pubblicato in Anno
Successful use of dupilumab for the treatment of atopic dermatitis on the genitals. a neglected anatomical site CLINICAL AND EXPERIMENTAL DERMATOLOGY 2022
Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study JOURNAL OF CLINICAL MEDICINE 2022
It's Never Too Late To Treat Chronic Spontaneous Urticaria With Omalizumab: Real-Life Data From A Multicenter Observational Study Focusing on Elderly Patients DERMATOLOGIC THERAPY 2021
New onset of alopecia areata in a patient with SARS-CoV-2 infection: Possible pathogenetic correlations? JOURNAL OF COSMETIC DERMATOLOGY 2021
Atopic dermatitis in adolescents. effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in italy DERMATOLOGIC THERAPY 2021
Effectiveness and safety of long-term dupilumab treatment in elderly patients with atopic dermatitis. a multicenter real-life observational study AMERICAN JOURNAL OF CLINICAL DERMATOLOGY 2021
Effects of dupilumab in type 1 neurofibromatosis coexisting with severe atopic dermatitis ANAIS BRASILEIROS DE DERMATOLOGIA 2021
Telogen effluvium after SARS-CoV-2 Infection. a series of cases and possible pathogenetic mechanisms SKIN APPENDAGE DISORDERS 2021
COVID-19. important updates and developments edited by franco rongioletti, MD, and leonard hoenig, MD Impact of COVID-19 on patients with atopic dermatitis CLINICS IN DERMATOLOGY 2021
Dupilumab in adolescents with moderate to severe atopic dermatitis. a 32-week real-world experience during the COVID-19 pandemic CLINICAL AND EXPERIMENTAL DERMATOLOGY 2021
Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 italian subjects. an observational study DERMATOLOGIC THERAPY 2021
Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2021
Dupilumab facial redness: histologic characterization on a series of four cases IMMUNOTHERAPY 2021
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in italy. data from the DA-COVID-19 registry ALLERGY 2021
COVID-19 infection and BNT162b2 vaccine triggering sarcoid-like lesions in the same patient Response to: Sarcoid-like reaction in a patient recovering from coronavirus disease 19 pneumonia ‫JAAD CASE REPORTS 2021
IFN-γ/IL-6 and related cytokines in chronic spontaneous urticaria: evaluation of their pathogenetic role and changes during omalizumab therapy INTERNATIONAL JOURNAL OF DERMATOLOGY 2020
Atopic dermatitis in the elderly Caucasian population: diagnostic clinical criteria and review of the literature INTERNATIONAL JOURNAL OF DERMATOLOGY 2020
"Toxic erythema" and eosinophilia associated to tocilizumab therapy in a COVID-19 patient JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2020
Potential clinical and serological predictors of chronic spontaneous urticaria relapse in patients under omalizumab treatment IMMUNOTHERAPY 2020
Dupilumab therapy of atopic dermatitis of the elderly. A multi-centre, real-life study JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma